The role of sodium glucose co-transporter inhibitors (SGLT2 i) and glucagon-like peptide 1 analogues  (GLP-1) in the management of type 2 diabetes

When to introduce SGLT2i and GLP-1 receptor in General Practice 

Associate Professor Terrence Diamond, Staff Specialist, Department of Endocrinology St George Hospital.

Learning outcomes

• Cover the diagnostics to determine the reversibility of diabetes

• Medications for the treatment of Type 2 diabetes : SGLT2 and GLP1

• Prescribing SGLT2 & GLP-1 medications for treatment of Type 2 diabetes 

• Cover the issues with evidence needed to manage patients in General Practice especially when a specialist Endocrine review is not yet indicated in order to prevent premature progression of diabetes complications 

Target audience: GPs, nurses and Pharmacists

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991

We are excited to bring you a breakfast webinar session as part of the St George Hospital education program for GPs. The Integrating Care Education program is an opportunity for hospital based specialists and their respective primary care specialists to meet in a forum to discuss the care of their patients. The topics covered will assist with patient care where it meets at this important interface. The program will cover topics relevant to both groups to improve movement to and from the two spheres of care. It will be delivered by hospital specialist with an interest or expertise in community based care.